holmes schreef op 15 februari 2025 12:55:
Intellia Therapeutics, Inc.
....... cash runway into the first half of 2027.
Pharvaris
....... estimated cash runway into 3Q2026
Kalvista
...... cash runway into second half 2027
Astria
....... cash sufficient to fund its operations into mid-2027
Ionis
Q4 + jaarcijfers op 19 februari 2025
Biocryst
jaarcijfers op 24.02.2025
Biomarin
jaarcijfers op19.02.2025Pharming
Q4/ FY 2024 op 13 maart 2025